Stay updated on Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T17:59:04.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content.
    Difference
    0.5%
    Check dated 2026-10-24T19:18:50.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T20:55:08.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T21:52:51.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The history log now reflects a new page revision (v3.7.0) replacing the previous v3.6.6, representing an internal update to the Study Record History interface.
    Difference
    0.1%
    Check dated 2026-09-19T20:35:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the Record History, replacing the previous v3.6.5, indicating an update to the page’s version history.
    Difference
    0.1%
    Check dated 2026-08-29T18:43:16.000Z thumbnail image

Stay in the know with updates to Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.